骨密度計の世界市場規模：技術別、エンドユーザー別、地域範囲別および予測

骨密度計の市場規模と予測

骨密度計の市場規模は、2024年に2億8,480万米ドルと評価され、2026～2032年にかけて4.73%のCAGRで成長し、2032年には3億9,848万米ドルに達すると予測されています。

骨密度計は、骨密度（BMD）を測定するために使用される特殊な医療機器であり、骨の単位体積当たりのミネラル含有量（主にカルシウム）を反映します。

二重エネルギーX線吸収法（DXA）を採用し、エネルギーレベルの異なる2本の低線量X線ビームを照射します。骨組織は軟組織とは異なるビームを吸収するため、正確なBMD測定が可能となります。

骨密度計は主に、低BMDと骨折リスクの増加を特徴とする骨粗鬆症の診断、骨粗鬆症治療の有効性のモニタリング、骨弱化状態の人の骨折リスクの評価に利用されます。

骨密度測定スキャンでは、患者はテーブルの上に横たわり、スキャナーのアームが検査する身体の特定の部位を通過します。処置は非侵襲的で痛みもなく、スキャンする部位の数にもよりますが、約10分から30分かかります。

骨密度測定の一般的な測定部位は、脊椎（腰椎）、股関節（大腿骨頸部と股関節全体）、前腕（橈骨）です。これらの部位は骨粗鬆症で骨折しやすく、骨密度の正確な測定値が得られることから選ばれています。

骨密度測定は、骨粗鬆症のリスクが高い閉経後の女性、一般的な骨の健康と骨折のリスクを評価するための高齢者、特定の病状を持つ人や骨密度に影響する薬を服用している人に一般的に使用されています。

骨密度計の世界市場力学

世界の骨密度計市場を形成している主要市場力学は以下の通りです。

主要市場促進要因

骨粗鬆症患者の増加：骨粗鬆症は、特に高齢者にとって深刻な健康問題です。早期診断とモニタリングのための骨密度計のニーズは、世界人口の高齢化に伴う骨粗鬆症と関連する骨の病気の有病率の上昇によって高まっています。

技術開発：骨密度測定の精度と効率は、携帯可能な高分解能機器の開発など、骨密度測定技術の開発によって向上しています。ヘルスケア産業が成長しているのは、このような技術向上が医療提供者を引きつけ、新しい機器に資金を投じる動機となっているためです。

高まる意識とスクリーニングプログラム：骨密度測定スクリーニングの必要性は、骨の健康に対する意識の高まりと、骨の問題を早期に発見することの重要性によってもたらされています。予防医療への骨密度計の使用は、政府プログラム、健康キャンペーン、患者教育の改善によって促進されています。

高齢者の増加：骨粗鬆症と骨減少症は骨に関連する2つの病気で、高齢化社会でより一般的になっています。高齢者の骨の健康を評価・管理するための骨密度測定ツールのニーズは、世界の高齢化とともに高まっています。

ヘルスケア支出の増大：特に発展途上国においてヘルスケア費用が上昇するにつれ、医療施設は骨密度測定器のようなより先進的技術を購入できるようになります。市場の拡大は、医療インフラの成長と医療サービスへのアクセスの容易さによって促進されます。

慢性疾患における診断的意義：骨密度評価は、骨粗鬆症の発見や、糖尿病、関節リウマチ、慢性腎臓病などの長期的な疾患における骨の健康状態の評価に不可欠です。さまざまな慢性疾患の診断と治療に骨密度測定が使用されるようになっていることが、市場拡大に拍車をかけています。

ヘルスケアにおける技術統合：骨密度測定装置を画像保存通信システム（PACS）や電子カルテ（EHR）と統合することで、ヘルスケア機関は患者ケアとワークフローの効率を改善できます。医療施設や診断ラボにおける骨密度測定装置の使用は、この統合によって促進されます。

保険適用と償還施策の奨励：骨密度測定検査に対するこれらの施策は、医療提供者にこれらの治療を提供するインセンティブを与え、骨密度測定装置の購入に資金を割り当て、それによって市場拡大を促進します。

主要課題

高コスト：骨密度測定装置の購入、維持、使用にはコストがかかります。小規模なヘルスケア施設や市場の施設では、この高コストのために運用が困難となる可能性があり、市場浸透が制限されます。

限られた償還規制：骨密度検査に対する償還規制は地域によって不均一または限定的である可能性があり、その結果、患者の経済的負担に影響し、骨密度計の需要を低下させる可能性があります。

技術的困難：骨密度測定技術の進歩は著しいが、精度、信頼性、使いやすさなどの問題により、普及率に影響が出る可能性があります。

代替技術との競合：骨密度測定法の市場には、同等の、あるいは付加的な情報を提供する他の画像モダリティや診断法との競合が存在する可能性があります。例えば、CTスキャンや超音波検査などがあります。

規制上の障害：医療機器に関する規制が厳しいため、骨密度計のアップグレードや新モデルの発売が妨げられ、市場拡大が阻害される可能性があります。

限られたアクセスと認知度：骨粗鬆症や骨密度検査の意義に関する知識不足のため、特定の地域や特定の層で骨密度計の需要が減少する可能性があります。

経済的要因：医療費の減少や高騰は、人々やヘルスケア施設の購買力に影響を与え、その結果、骨密度測定装置への投資額が減少する可能性があります。

患者の懸念：骨密度測定装置の需要は、患者が放射線被曝や手術中の不快感を懸念して骨密度測定に消極的であることから影響を受ける可能性があります。

主要動向

高齢者の増加と骨粗鬆症リスクの増加：世界の高齢化は骨粗鬆症の有病率の上昇につながり、診断とモニタリングのための骨密度計の需要を促進しています。

技術の進歩とマルチモダリティイメージング：DEXA技術の進歩、デジタル検出器との統合、末梢定量CT（pQCT）によるマルチモダリティイメージングの探求は、精度と効率を高め、より包括的な骨の健康評価を提供しています。

早期診断と疾病管理における採用の拡大：骨粗鬆症の早期発見と介入は極めて重要です。骨密度計は予防医療や治療効果のモニタリングにますます使用されるようになってきています。

携帯型と家庭用骨密度計への注目：携帯型と家庭用骨密度測定器は、その利便性と、特にリスクのある集団にとって、より多くの患者が利用できる可能性があることから、支持を集めています。

認知度の向上と検診プログラム：骨粗鬆症に対する一般市民の意識の高まりと骨の健康診断プログラムへの取り組みが、市場にプラスの影響を与えています。

償還施策と費用対効果分析：償還施策と費用対効果分析は、骨密度計の採用に関する病院やクリニックの意思決定に影響を与える重要な要因です。

新興市場と地域成長の可能性：骨密度計市場は、人口の高齢化とヘルスケア支出の増加により、中国やインドのような新興経済国で大きな成長が見込まれています。

データセキュリティと電子カルテとの統合：データセキュリティと骨密度計データと電子カルテのシームレスな統合に重点を置くことがますます重要になってきています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主要調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 骨密度計市場：技術別

• 軸方向骨密度測定（DXA）
• 末梢骨密度測定（pDXA）
• 定量的超音波（QUS）

第5章 骨密度計市場：エンドユーザー別

• 病院
• 専門クリニック
• イメージングセンター
• その他

第6章 地域分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第7章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第8章 競合情勢

• 主要企業
• 市場シェア分析

第9章 企業プロファイル

• GE Healthcare
• Hologic Inc.
• Siemens Healthineers
• Swissray Global Healthcare Holding Ltd.
• BeamMed Ltd.
• Osteosys Co., Ltd.
• Diagnostic Medical Systems Group（DMS）
• Medonica Co. Ltd.
• CompuMed, Inc.
• Lone Oak Medical Technologies LLC

第10章 市場展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第11章 市場展望付録

• 略語リスト
• 供給源と参考文献

Bone Densitometer Market Size And Forecast

Bone Densitometer Market size was valued at USD 284.8 Million in 2024 and is projected to reach USD 398.48 Million by 2032, growing at a CAGR of 4.73 % from 2026 to 2032.

A bone densitometer is a specialized medical device used to measure bone mineral density (BMD), reflecting the amount of mineral content (primarily calcium) per unit volume of bone.

It employs dual-energy X-ray absorptiometry (DXA), emitting two low-dose X-ray beams with differing energy levels. Bone tissue absorbs these beams differently than soft tissue, allowing for precise BMD measurement.

Bone densitometers are primarily utilized for, diagnosing osteoporosis, characterized by low BMD and increased fracture risk, monitoring the efficacy of osteoporosis treatments, and assessing fracture risk in individuals with bone-weakening conditions.

During a Bone Densitometry scan, the patient lies on a table while the scanner arm passes over the specific body part being examined. The procedure is non-invasive and painless, taking about 10 to 30 minutes depending on the number of sites scanned.

Common measurement sites for Bone Densitometry include the spine (lumbar vertebrae), hip (femoral neck and total hip), and forearm (radius). These sites are chosen because they are prone to fractures in osteoporosis and provide accurate readings of bone density.

Bone Densitometry is commonly used for postmenopausal women, who are at higher risk for osteoporosis, older adults to assess general bone health and fracture risk, and individuals with certain medical conditions or on medications that affect bone density.

Global Bone Densitometer Market Dynamics

The key market dynamics that are shaping the global bone densitometer market include:

Key Market Drivers

Growing Osteoporosis Prevalence: Osteoporosis is a serious health issue, especially for the elderly population. The need for bone densitometers for early diagnosis and monitoring is being driven by the rising prevalence of osteoporosis and related bone ailments as the world's population ages.

Technological Developments: The accuracy and efficiency of bone density measurements are improved by developments in bone densitometry technology, such as the creation of portable, high-resolution instruments. The healthcare industry is growing because of these technological improvements, which draw in providers and motivate them to spend money on new equipment.

Growing Awareness and Screening Programmes: The need for bone densitometry screening is driven by growing awareness of bone health and the significance of early bone problem detection. The use of bone densitometers for preventive healthcare is facilitated by government programmes, health campaigns, and improved patient education.

Growing Older Population: Osteoporosis and osteopenia are two bone-related illnesses that are more common in the ageing population. The need for bone densitometry tools to evaluate and manage bone health in the senior population is rising in tandem with the worldwide ageing population.

Growing Healthcare Expenditure: As healthcare costs rise, especially in developing nations, medical facilities can purchase more sophisticated technology, such as bone densitometers. Market expansion is facilitated by the growing healthcare infrastructure and the ease of access to healthcare services.

Diagnostic Significance in Chronic Illnesses: Bone density evaluations are essential for detecting osteoporosis as well as evaluating the health of the bones in long-term ailments such as diabetes, rheumatoid arthritis, and chronic kidney disease. Market expansion is fueled by the growing use of bone densitometry in the diagnosis and treatment of a range of chronic illnesses.

Technological Integration in Healthcare: By integrating bone densitometry equipment with picture archiving and communication systems (PACS) and electronic health records (EHRs), healthcare institutions can improve patient care and workflow efficiency. The use of bone densitometers in medical facilities and diagnostic labs is encouraged by this integration.

Encouraging Insurance Coverage and Reimbursement Policies: These Policies for bone densitometry examinations incentivize healthcare providers to deliver these treatments and allocate funds towards purchasing bone densitometry equipment, thereby driving market expansion.

Key Challenges:

High Cost: The purchase, upkeep, and use of bone densitometers can be costly. Smaller healthcare facilities or those in developing countries may find it prohibitive to operate due to this high cost, which would restrict market penetration.

Limited Reimbursement Regulations: Reimbursement regulations for bone density testing may be uneven or limited in various regions, which may impact patient affordability and consequently lower demand for bone densitometers.

Technological Difficulties: Although bone densitometry technology has come a long way, adoption rates may still be impacted by issues with accuracy, dependability, and usability.

Rivalry from Alternative Technologies: There may be rivalry in the market for bone densitometry from other imaging modalities or diagnostic procedures that offer comparable or additional information. Examples of these procedures include CT scans and ultrasounds.

Regulatory Obstacles: Tight regulations pertaining to medical equipment may impede the release of upgraded or new bone densitometer models, hence impeding market expansion.

Limited Access and Awareness: There may be a decreased demand for bone densitometers in specific areas or among certain demographic groups due to a lack of knowledge about osteoporosis and the significance of bone density testing.

Economic Factors: Declines or spikes in healthcare costs can affect people's and healthcare facilities' purchasing power, which can result in a decrease in the amount of money invested in bone densitometry equipment.

Patient Concerns: The demand for bone densitometers may be impacted by patients' reluctance to undertake bone density testing because they are worried about radiation exposure or discomfort during the operation.

Key Trends:

Rising Geriatric Population and Increased Osteoporosis Risk: An aging population globally leads to a higher prevalence of osteoporosis, driving the demand for bone densitometers for diagnosis and monitoring.

Technological Advancements and Multi-Modality Imaging: Advancements in DEXA technology, integration with digital detectors, and exploration of multi-modality imaging with peripheral quantitative CT (pQCT) are increasing accuracy, and efficiency, and offering more comprehensive bone health assessment.

Growing Adoption in Early Diagnosis and Disease Management: Early detection and intervention for osteoporosis are crucial. Bone densitometers are becoming increasingly used for preventive care and monitoring treatment response.

Focus on Portable and Home-Based Bone Densitometers: Portable and home-based bone densitometers are gaining traction due to their convenience and potential for wider patient access, particularly for at-risk populations.

Increasing Awareness and Screening Programs: Growing public awareness about osteoporosis and initiatives for bone health screening programs are positively impacting the market.

Reimbursement Policies and Cost-Effectiveness Analysis: Reimbursement policies and cost-effectiveness analyses are crucial factors influencing hospital and clinic decisions regarding bone densitometer adoption.

Emerging Markets and Regional Growth Potential: The Bone Densitometer Market is expected to see significant growth in emerging economies like China and India due to their aging populations and rising healthcare expenditure.

Data Security and Integration with Electronic Health Records: Focus on data security and seamless integration of bone densitometer data with electronic health records is becoming increasingly important.

Global Bone Densitometer Market Regional Analysis

Here is a more detailed regional analysis of the global bone densitometer market:

North America

North America is significantly dominating the bone densitometer market and is expected to continue its growth throughout the forecast period.

North America dominates the worldwide Bone Densitometer market in terms of both size and revenue. This dominance is due to increased healthcare spending, superior medical infrastructure, and early adoption of innovative medical technologies.

The region benefits from ongoing technical advances in medical imaging and diagnostics, which drive demand for improved bone densitometer systems.

North America is home to many of the world's main manufacturers of bone densitometers, which contributes to the region's dominant position. To preserve market leadership, these organizations prioritize innovation and product development.

In North America, there is a significant emphasis on preventative healthcare and osteoporosis screening programs, which drives up demand for Bone Densitometers for early detection and treatment.

A well-established regulatory system protects product safety and efficacy, giving healthcare practitioners and patients confidence in using Bone Densitometer technology.

North America is a key location for medical technology research and development, which promotes ongoing innovation in Bone Densitometer systems. This innovation fuels market growth and ensures the region's dominance.

The region's significant healthcare expenditure supports advanced diagnostic technology such as bone densitometers, assuring widespread availability in clinical settings.

North America has a well-established healthcare system, with many healthcare facilities outfitted with advanced diagnostic equipment, including Bone Densitometers.

Asia Pacific

Asia Pacific is anticipated to be the fastest-growing region in the bone densitometer market. Economic development, an aging population, and an increased frequency of osteoporosis and related disorders are all contributing to Asia Pacific's rapid growth in healthcare spending.

Countries such as China, India, and Japan are experiencing rapid growth in healthcare infrastructure and medical device usage, including Bone Densitometers.

Governments in Asia Pacific are increasingly focusing on improving healthcare accessibility and quality, including investments in innovative medical equipment like bone densitometers.

Healthcare practitioners and consumers are becoming more aware of the importance of bone health and early detection of osteoporosis, which is driving up demand for Bone Densitometer devices.

Rapid urbanization and economic expansion in Asia Pacific have resulted in enhanced healthcare infrastructure and higher adoption rates of modern medical technologies such as bone densitometers.

The region's aging population, together with higher life expectancy, is pushing up demand for Bone Densitometers to effectively manage osteoporosis and related disorders.

Governments across the Asia Pacific are investing in healthcare infrastructure development and programs to improve healthcare access, including the purchase of diagnostic equipment such as bone densitometers.

Local and foreign manufacturers are producing technologically improved Bone Densitometer systems designed specifically for Asia Pacific markets, increasing acceptance rates.

Global Bone Densitometer Market: Segmentation Analysis

The Global Bone Densitometer Market is segmented based on Technology, End-User, And Geography.

Bone Densitometer Market, By Technology

• Axial Bone Densitometry (DXA)
• Peripheral Bone Densitometry (pDXA)
• Quantitative Ultrasound (QUS)

Based on Technology, the market is bifurcated into Axial Bone Densitometry (DXA), Peripheral Bone Densitometry (pDXA), and Quantitative Ultrasound (QUS). Axial Bone Densitometry (DXA) dominates the Bone Densitometer market because to its high precision and dependability in detecting bone mineral density at important areas such as the spine and hip, which are particularly vulnerable to osteoporotic fractures. Its broad use in clinical settings for osteoporosis diagnosis and fracture risk assessment, together with its capacity to give complete and exact data, strengthens its position as the industry leader. Furthermore, ongoing technical improvements and endorsements from major health organizations increase its use and desirability among healthcare providers.

Bone Densitometer Market, By End User

• Hospitals
• Specialty Clinics
• Imaging Centers

Based on End Users, the market is bifurcated into Hospitals, Specialty Clinics, and Imaging Centers. Hospitals lead the Bone Densitometer market because of their enormous infrastructure and capacity to provide comprehensive diagnostic services, such as advanced imaging technologies. They are frequently outfitted with cutting-edge bone densitometry technology, such as DXA machines, which are critical for detecting and monitoring osteoporosis and other bone-related diseases. The large number of patients in hospitals, together with their ability to handle complex situations and provide integrated treatment, ensures a consistent need for bone densitometry services. Furthermore, the presence of specialist departments and competent healthcare personnel improves the reliability and accuracy of bone density evaluations, bolstering hospitals' market-leading position.

Bone Densitometer Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Global Bone Densitometer Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is significantly dominating the bone densitometer market and is expected to continue its growth throughout the forecast period, owing to several variables. North America dominates the worldwide Bone Densitometer market in terms of both size and revenue. This dominance is due to increased healthcare spending, superior medical infrastructure, and early adoption of innovative medical technologies. The region benefits from ongoing technical advances in medical imaging and diagnostics, which drive demand for improved bone densitometer systems.

Key Players

• The "Global Bone Densitometer Market" study report will provide valuable insight emphasizing the global market. The major players in the market are GE Healthcare, Hologic Inc., DMS Imaging, Swissray International Inc., Osteometer Meditech Inc., Echolight S.p.A., Medonica Co. Ltd, Hitachi Ltd., Siemens Healthineers, and Canon Medical Systems Corporation

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In March 2023, GE Healthcare announced the launch of an updated version of their Lunar iDXA system, featuring enhanced software capabilities to improve diagnostic accuracy and patient throughput.
• In April 2022, Hologic Inc. expanded its product line with the introduction of the Horizon DXA system, designed to offer advanced imaging capabilities for comprehensive bone health assessment.
• In February 2023, DMS Imaging unveiled a new series of portable bone densitometers aimed at increasing accessibility in rural and remote healthcare settings, enhancing the ability to diagnose and treat osteoporosis.
• In January 2023, Swissray International Inc. launched their new Digital Radiography (DR) solutions that integrate bone densitometry capabilities, streamlining diagnostic processes in clinical settings.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Bone Densitometer Market, By technology

• Axial bone densitometry (DXA)
• Peripheral bone densitometry (pDXA)
• Quantitative ultrasound (QUS)

5. Bone Densitometer Market, By end-user

• Hospitals
• Specialty clinics
• Imaging centers
• Other end-users

6. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles

• GE Healthcare
• Hologic Inc.
• Siemens Healthineers
• Swissray Global Healthcare Holding Ltd.
• BeamMed Ltd.
• Osteosys Co., Ltd.
• Diagnostic Medical Systems Group (DMS)
• Medonica Co. Ltd.
• CompuMed, Inc.
• Lone Oak Medical Technologies LLC

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References